Medical practice and related services

Tender description

Leicestershire County Council and Rutland County Council wish to undertake a procurement process to identify and appoint a number of service providers to provide public health community-based services. These services are divided into the following four lots: Lot 1 CBS20-21(01) Provision of Smoking Cessation Pharmacotherapy. Lot 2 CBS20-21(02) Provision of NHS Health Checks. Lot 3 CBS20-21(03) Provision of intrauterine device (IUD), intrauterine system (IUS) and sub-dermal implants (SDI) Fitting and Removal Service for contraceptive purposes and for gynaecological (non-contraceptive) purposes including management of menorrhagia and hormone replacement therapy (HRT). Lot 4 CBS20-21(04) Provision of oral Emergency Contraception (EC) to women under 25 years of age. The stop smoking service forms part of a wider tobacco control programme. The stop smoking service is targeted at those individuals who smoke and are thinking of either quitting or cutting down their tobacco use. The stop smoking service will identify those smokers who want and are eligible to use prescription-only medication (Varenicline/Champix) as part of their overall treatment plan. In the case of Varenicline//Champix being agreed as part of the treatment plan then the stop smoking service will send the smoker a voucher code and the smoker will be given the option to go to aparticipating community pharmacy to redeem the prescribed medication. The prescription will be filled following an assessment by the healthcare professional for suitability against the PGD inclusion and exclusion criteria and the summary of product characteristic indications and contraindications. Varenicline is no longer a black triangle drug. The stop smoking service is available to individuals aged 12 and above (18 and above for the use of Varenicline/Champix) who live, work or are registered with a GP within Leicestershire County. To reduce levels of cardiovascular disease (CVD) risk and associated premature mortality in Leicestershire County and Rutland County through primary care; ensuring systematic and proactive identification and management of patients with 20 % or greater risk of CVD event in next 10 years (based on a 10-year risk equation). This is in line with the 2016 NICE Guidance on vascular risk assessment. — the provision, monitoring, fitting and removal of intrauterine devices (IUDs), intrauterine systems (IUSs) and/or sub-dermal implants (SDIs) to a practice population as part of a wider range of contraceptive options provided. — the provision, review and subsequent removal, of Levonorgestrel Intrauterine System (LNG-IUS) for gynaecological (non-contraceptive) purposes including management of menorrhagia and hormone replacement therapy (HRT) commissioned on behalf of the Clinical Commissioning Group (CCG). Ongoing management of gynaecological issues are not included in this agreement. (The element of care covered by this specification in relation to use of LNG-IUS for management of gynaecological conditions such as menorrhagia is detailed in Appendix B.) The aim of this service is to reduce unintended conception and improve sexual health for young people by: — provision of free oral emergency contraception (Ulipristal acetate (UPA) or Levonelle (LNG) to women under 25 years in Leicestershire and Rutland from accessible community based settings that provide a timely, open access service in line with the criteria and patient group directions (PGDs) as detailed in this specification; — active promotion of the online chlamydia screening programme, online STI testing platform, general awareness of chlamydia and other sexual health issues to promote good sexual health and signposting to other sexual health services as necessary; — provision of clear signposting and advice in relation to sexual health services; — strengthening of local network of contraceptive and sexual health services to help ensure easy and swift access to advice and services; — provision of advice on the use of condoms to prevent infection and of public health information on safer sex practices to increase the knowledge of risks associated with STIs. Providers will be expected as a minimum to engage with and support the local C-Card condom distribution delivery model; — provision of information packs and signage as detailed below: (a) Ulipristal acetate or Levonorgestrel (In accordance with the relevant PGD criteria); (b) Patient information sheet (Appendix in the relevant PGD); (c) Condoms and information pack as provided by the LLR Integrated Sexual Health Service (ISHS); (d) Display of signage to promote service availability.